| 000 | 01544 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250514010133.0 | ||
| 264 | 0 | _c20011204 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a0305-7453 | ||
| 024 | 7 |
_a10.1093/jac/48.3.383 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNavarro, F | |
| 245 | 0 | 0 |
_aCMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000). _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cSep 2001 |
||
| 300 |
_a383-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance, Bacterial _xphysiology |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple _xphysiology |
| 650 | 0 | 4 |
_aEnterobacteriaceae _xenzymology |
| 650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKlebsiella _xdrug effects |
| 650 | 0 | 4 |
_aKlebsiella pneumoniae _xdrug effects |
| 650 | 0 | 4 |
_aProteus mirabilis _xdrug effects |
| 650 | 0 | 4 |
_aSalmonella enterica _xdrug effects |
| 650 | 0 | 4 | _aSpain |
| 650 | 0 | 4 |
_abeta-Lactamases _xmetabolism |
| 700 | 1 | _aPerez-Trallero, E | |
| 700 | 1 | _aMarimon, J M | |
| 700 | 1 | _aAliaga, R | |
| 700 | 1 | _aGomariz, M | |
| 700 | 1 | _aMirelis, B | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 48 _gno. 3 _gp. 383-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/48.3.383 _zAvailable from publisher's website |
| 999 |
_c11456828 _d11456828 |
||